Beyond Air (XAIR) Competitors

$0.57 0.00 (-0.52%)

Closing price 03:59 PM Eastern

Extended Trading

$0.58 +0.01 (+1.22%)

As of 04:10 PM Eastern

XAIR vs. MLSS, OSRH, FEMY, ICCM, and POAI

Should you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Milestone Scientific (MLSS), OSR (OSRH), Femasys (FEMY), IceCure Medical (ICCM), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Milestone Scientific?

Beyond Air (NASDAQ:XAIR) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

: Milestone Scientific has higher revenue and earnings than Beyond Air. Milestone Scientific is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Beyond Air $6.92M 1.09 -$46.62M -$5.43 N/A
Milestone Scientific $8.97M 3.53 -$6.93M -$0.06 N/A
: Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
: Beyond Air presently has a consensus price target of $10.00, suggesting a potential upside of 1,642.16%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 153.81%. Given Beyond Air's higher possible upside, equities analysts clearly believe Beyond Air is more favorable than Milestone Scientific.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beyond Air
1 Sell rating(s)
0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
Milestone Scientific
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
: In the previous week, Beyond Air's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.
Company Overall Sentiment
Beyond Air Neutral
Milestone Scientific Neutral
: 31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 17.0% of Beyond Air shares are owned by company insiders. Comparatively, 12.5% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: Milestone Scientific has a net margin of -52.01% compared to Beyond Air's net margin of -447.75%. Milestone Scientific's return on equity of -60.26% beat Beyond Air's return on equity.
Company Net Margins Return on Equity Return on Assets
Beyond Air -447.75% -268.82% -98.49%
Milestone Scientific -52.01% -60.26% -40.23%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$6.92M	1.09	-$46.62M	-$5.43	N/A
Milestone Scientific	$8.97M	3.53	-$6.93M	-$0.06	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Overall Sentiment
Beyond Air	Neutral
Milestone Scientific	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Summary

Milestone Scientific beats Beyond Air on 9 of the 14 factors compared between the two stocks.

How does Beyond Air compare to OSR?

OSR (NASDAQ:OSRH) and Beyond Air (NASDAQ:XAIR) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

: OSR has higher earnings, but lower revenue than Beyond Air. OSR is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OSR $2.91M 5.94 -$27.06M -$1.28 N/A
Beyond Air $6.92M 1.09 -$46.62M -$5.43 N/A
: OSR has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500.
: Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 1,642.16%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than OSR.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OSR
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Beyond Air
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: In the previous week, OSR had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for OSR and 0 mentions for Beyond Air. OSR's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.
Company Overall Sentiment
OSR Neutral
Beyond Air Neutral
: 55.3% of OSR shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 60.6% of OSR shares are owned by company insiders. Comparatively, 17.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Beyond Air has a net margin of -447.75% compared to OSR's net margin of -619.82%. OSR's return on equity of -13.53% beat Beyond Air's return on equity.
Company Net Margins Return on Equity Return on Assets
OSR -619.82% -13.53% -10.17%
Beyond Air -447.75% -268.82% -98.49%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91M	5.94	-$27.06M	-$1.28	N/A
Beyond Air	$6.92M	1.09	-$46.62M	-$5.43	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Company	Overall Sentiment
OSR	Neutral
Beyond Air	Neutral

Company	Net Margins	Return on Equity	Return on Assets
OSR	-619.82%	-13.53%	-10.17%
Beyond Air	-447.75%	-268.82%	-98.49%

Summary

OSR beats Beyond Air on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Femasys?

Femasys (NASDAQ:FEMY) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

: Femasys has higher earnings, but lower revenue than Beyond Air. Femasys is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Femasys $2.29M 10.65 -$18.63M -$0.50 N/A
Beyond Air $6.92M 1.09 -$46.62M -$5.43 N/A
: Femasys has a beta of -2.26, indicating that its stock price is 326% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500.
: Femasys presently has a consensus price target of $5.50, suggesting a potential upside of 1,261.39%. Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 1,642.16%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than Femasys.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
1 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.60
Beyond Air
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: In the previous week, Femasys had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Femasys and 0 mentions for Beyond Air. Femasys' average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.
Company Overall Sentiment
Femasys Neutral
Beyond Air Neutral
: 65.3% of Femasys shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 7.6% of Femasys shares are owned by company insiders. Comparatively, 17.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Beyond Air has a net margin of -447.75% compared to Femasys' net margin of -812.74%. Beyond Air's return on equity of -268.82% beat Femasys' return on equity.
Company Net Margins Return on Equity Return on Assets
Femasys -812.74% -534.94% -116.29%
Beyond Air -447.75% -268.82% -98.49%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	10.65	-$18.63M	-$0.50	N/A
Beyond Air	$6.92M	1.09	-$46.62M	-$5.43	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Company	Overall Sentiment
Femasys	Neutral
Beyond Air	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-812.74%	-534.94%	-116.29%
Beyond Air	-447.75%	-268.82%	-98.49%

Summary

Beyond Air beats Femasys on 8 of the 15 factors compared between the two stocks.

How does Beyond Air compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

: 0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 17.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: IceCure Medical has a net margin of -445.61% compared to Beyond Air's net margin of -447.75%. IceCure Medical's return on equity of -221.04% beat Beyond Air's return on equity.
Company Net Margins Return on Equity Return on Assets
IceCure Medical -445.61% -221.04% -118.89%
Beyond Air -447.75% -268.82% -98.49%
: IceCure Medical has higher earnings, but lower revenue than Beyond Air. IceCure Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IceCure Medical $3.38M 6.72 -$15.06M -$0.24 N/A
Beyond Air $6.92M 1.09 -$46.62M -$5.43 N/A
: In the previous week, IceCure Medical had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for IceCure Medical and 0 mentions for Beyond Air. IceCure Medical's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.
Company Overall Sentiment
IceCure Medical Neutral
Beyond Air Neutral
: IceCure Medical presently has a consensus price target of $2.64, suggesting a potential upside of 841.07%. Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 1,642.16%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than IceCure Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
Beyond Air
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: IceCure Medical has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-445.61%	-221.04%	-118.89%
Beyond Air	-447.75%	-268.82%	-98.49%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	6.72	-$15.06M	-$0.24	N/A
Beyond Air	$6.92M	1.09	-$46.62M	-$5.43	N/A

Company	Overall Sentiment
IceCure Medical	Neutral
Beyond Air	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

IceCure Medical and Beyond Air tied by winning 7 of the 14 factors compared between the two stocks.

How does Beyond Air compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

: 9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by company insiders. Comparatively, 17.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: Beyond Air has a net margin of -447.75% compared to Predictive Oncology's net margin of -5,065.23%. Beyond Air's return on equity of -268.82% beat Predictive Oncology's return on equity.
Company Net Margins Return on Equity Return on Assets
Predictive Oncology -5,065.23% -732.73% -235.55%
Beyond Air -447.75% -268.82% -98.49%
: Predictive Oncology has higher earnings, but lower revenue than Beyond Air. Predictive Oncology is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Predictive Oncology $1.66M 10.60 -$12.66M -$13.50 N/A
Beyond Air $6.92M 1.09 -$46.62M -$5.43 N/A
: In the previous week, Predictive Oncology had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Predictive Oncology and 0 mentions for Beyond Air. Predictive Oncology's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.
Company Overall Sentiment
Predictive Oncology Neutral
Beyond Air Neutral
: Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 1,642.16%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than Predictive Oncology.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Beyond Air
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: Predictive Oncology has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
Beyond Air	-447.75%	-268.82%	-98.49%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	10.60	-$12.66M	-$13.50	N/A
Beyond Air	$6.92M	1.09	-$46.62M	-$5.43	N/A

Company	Overall Sentiment
Predictive Oncology	Neutral
Beyond Air	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Beyond Air beats Predictive Oncology on 11 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.57M	$3.39B	$6.25B	$11.87B
Dividend Yield	N/A	2.20%	2.73%	5.21%
P/E Ratio	-0.11	38.92	29.03	28.47
Price / Sales	1.09	154.75	476.10	60.92
Price / Cash	N/A	57.88	27.62	36.52
Price / Book	0.17	7.03	9.67	6.67
Net Income	-$46.62M	$23.62M	$3.55B	$332.53M
7 Day Performance	12.75%	3.78%	1.75%	2.03%
1 Month Performance	-19.11%	7.30%	5.66%	9.23%
1 Year Performance	-86.20%	67.15%	34.42%	39.62%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	2.4668 of 5 stars	$0.57 -0.5%	$10.00 +1,642.2%	N/A	$7.57M	$6.92M	N/A	70
MLSS Milestone Scientific	1.2228 of 5 stars	$0.33 -4.1%	$1.00 +206.8%	N/A	$26.22M	$8.97M	N/A	30
OSRH OSR	0.9242 of 5 stars	$0.74 +2.8%	N/A	N/A	$23.98M	$2.91M	N/A	N/A	Gap Down
FEMY Femasys	1.8042 of 5 stars	$0.37 -4.7%	$5.50 +1,374.5%	N/A	$23.62M	$2.29M	N/A	30	News Coverage Upcoming Earnings Gap Up
ICCM IceCure Medical	2.1551 of 5 stars	$0.27 -3.7%	$2.64 +863.1%	N/A	$23.06M	$3.38M	N/A	60	News Coverage Analyst Forecast High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. MLSS, OSRH, FEMY, ICCM, and POAI

How does Beyond Air compare to Milestone Scientific?

Summary

How does Beyond Air compare to OSR?

Summary

How does Beyond Air compare to Femasys?

Summary

How does Beyond Air compare to IceCure Medical?

Summary

How does Beyond Air compare to Predictive Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. MLSS, OSRH, FEMY, ICCM, and POAI

How does Beyond Air compare to Milestone Scientific?

Summary

How does Beyond Air compare to OSR?

Summary

How does Beyond Air compare to Femasys?

Summary

How does Beyond Air compare to IceCure Medical?

Summary

How does Beyond Air compare to Predictive Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools